Education/CredentialsPh.D. : West Virginia University (Pharmaceutical and Pharmacological Sciences)B.S.: Canisius College (Biochemistry) Contact Information Medical Sciences Building 3202 Office 513-558-0333 Email robsonmw@ucmail.uc.edu Research InterestsTraumatic brain injuries (TBI) are a leading cause of disability in populations across the globe. Diverse environmental factors can lead to various forms of TBI, many of which result in the generation of chronic, neuropsychiatric comorbitidies such as depression, anxiety and social withdrawal. Our current understanding of the neuronal and molecular mechanisms that contribute to the generation of these neuropsychiatric complications remains limited. The focus of the Robson Laboratory is to enhance ou... Peer Reviewed Publications Chen, Yanting; Lu, Xiaohan; Whitney, Raeann L; Li, Yu; Robson, Matthew J; Blakely, Randy D; Chi, Jen-Tsan; Crowley, Steven D; Privratsky, Jamie R 2024. Novel anti-inflammatory effects of the IL-1 receptor in kidney myeloid cells following ischemic AKI. Frontiers in molecular biosciences, 11 , 1366259Hetzer, S M; O'Connell, C; Lallo, V; Robson, M; Evanson, N K 2024. Model matters: Differential outcomes in traumatic optic neuropathy pathophysiology between blunt and blast-wave mediated head injuries. Experimental neurology, 372 , 114613O'Connell, Christopher J; Brown, Ryan S; Peach, Taylor M; Traubert, Owen D; Schwierling, Hana C; Notorgiacomo, Gabrielle A; Robson, Matthew J 2024. Strain in the Midbrain: Impact of Traumatic Brain Injury on the Central Serotonin System. Brain sciences, 14 1, O'Connell, Christopher J; Reeder, Evan L; Hymore, Jacob A; Brown, Ryan S; Notorgiacomo, Gabrielle A; Collins, Sean M; Gudelsky, Gary A; Robson, Matthew J 2024. Transcriptomic dynamics governing serotonergic dysregulation in the dorsal raphe nucleus following mild traumatic brain injury. Experimental neurology, 374 , 114695Luis, Tiago C; Barkas, Nikolaos; Carrelha, Joana; Giustacchini, Alice; Mazzi, Stefania; Norfo, Ruggiero; Wu, Bishan; Aliouat, Affaf; Guerrero, Jose A; Rodriguez-Meira, Alba; Bouriez-Jones, Tiphaine; Macaulay, Iain C; Jasztal, Maria; Zhu, Guangheng; Ni, Heyu; Robson, Matthew J; Blakely, Randy D; Mead, Adam J; Nerlov, Claus; Ghevaert, Cedric; Jacobsen, Sten Eirik W 2023. Perivascular niche cells sense thrombocytopenia and activate hematopoietic stem cells in an IL-1 dependent manner. Nature communications, 14 1, 6062Reeder, Evan L; O'Connell, Christopher J; Collins, Sean M; Traubert, Owen D; Norman, Sophia V; Cáceres, Román A; Sah, Renu; Smith, David W; Robson, Matthew J 2023. Increased Carbon Dioxide Respiration Prevents the Effects of Acceleration/Deceleration Elicited Mild Traumatic Brain Injury. Neuroscience, 509 , 20-35Ren, Jiafa; Liu, Kang; Wu, Buyun; Lu, Xiaohan; Sun, Lianqin; Privratsky, Jamie R; Xing, Changying; Robson, Matthew J; Mao, Huijuan; Blakely, Randy D; Abe, Koki; Souma, Tomokazu; Crowley, Steven D 2023. Divergent Actions of Renal Tubular and Endothelial Type 1 IL-1 Receptor Signaling in Toxin-Induced AKI. Journal of the American Society of Nephrology : JASN, 34 10, 1629-1646Singer, Kathleen E; McGlone, Emily D; Collins, Sean M; Wallen, Taylor E; Morris, Mackenzie C; Schuster, Rebecca M; England, Lisa G; Robson, Matthew J; Goodman, Michael D 2023. Propranolol Reduces p-tau Accumulation and Improves Behavior Outcomes in a Polytrauma Murine Model. The Journal of surgical research, 282 , 183-190Collins, Sean M; O'Connell, Christopher J; Reeder, Evan L; Norman, Sophia V; Lungani, Kainat; Gopalan, Poornima; Gudelsky, Gary A; Robson, Matthew J 2022. Altered Serotonin 2A (5-HT2A) Receptor Signaling Underlies Mild TBI-Elicited Deficits in Social Dominance. Frontiers in pharmacology, 13 , 930346O'Connell, Christopher J; Reeder, Evan L; Collins, Sean M; Lungani, Kainat; Norman, Sophia V; Robson, Matthew J 2022. Mild traumatic brain injury elicits time- and region-specific reductions in serotonin transporter protein expression and uptake capacity. Neuroreport, 33 14, 612-616Reeder, Evan L; Liber, Mei-Ling; Traubert, Owen D; O'Connell, Christopher J; Turner, Ryan C; Robson, Matthew J 2022. Effect of driver gas composition on production of scaled Friedlander waveforms in an open-ended shock tube model. Biomedical physics & engineering express, 8 6, Ren, Jiafa; Lu, Xiaohan; Hall, Gentzon; Privratsky, Jamie R; Robson, Matthew J; Blakely, Randy D; Crowley, Steven D 2022. IL-1 receptor signaling in podocytes limits susceptibility to glomerular damage. American journal of physiology. Renal physiology, 322 2, F164-F174Logsdon, Aric F; Lucke-Wold, Brandon P; Turner, Ryan C; Collins, Sean M; Reeder, Evan L; Huber, Jason D; Rosen, Charles L; Robson, Matthew J; Plattner, Florian 2020. Low-intensity Blast Wave Model for Preclinical Assessment of Closed-head Mild Traumatic Brain Injury in Rodents. Journal of visualized experiments : JoVE, 165, Quinlan, Meagan A; Robson, Matthew J; Ye, Ran; Rose, Kristie L; Schey, Kevin L; Blakely, Randy D 2020. Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant. Frontiers in molecular neuroscience, 13 , 89Sturchio, Andrea; Marsili, Luca; Vizcarra, Joaquin A; Dwivedi, Alok K; Kauffman, Marcelo A; Duker, Andrew P; Lu, Peixin; Pauciulo, Michael W; Wissel, Benjamin D; Hill, Emily J; Stecher, Benjamin; Keeling, Elizabeth G; Vagal, Achala S; Wang, Lily; Haslam, David B; Robson, Matthew J; Tanner, Caroline M; Hagey, Daniel W; El Andaloussi, Samir; Ezzat, Kariem; Fleming, Ronan M T; Lu, Long J; Little, Max A; Espay, Alberto J 2020. Phenotype-Agnostic Molecular Subtyping of Neurodegenerative Disorders: The Cincinnati Cohort Biomarker Program (CCBP). Frontiers in aging neuroscience, 12 , 553635Khalid, Fatima; Yang, George L; McGuire, Jennifer L; Robson, Matthew J; Foreman, Brandon; Ngwenya, Laura B; Lorenz, John N 2019. Autonomic dysfunction following traumatic brain injury: translational insights. Neurosurgical focus, 47 5, E8Liu, Xiaoyu; Nemeth, Daniel P; McKim, Daniel B; Zhu, Ling; DiSabato, Damon J; Berdysz, Olimpia; Gorantla, Gowthami; Oliver, Braedan; Witcher, Kristina G; Wang, Yufen; Negray, Christina E; Vegesna, Rekha S; Sheridan, John F; Godbout, Jonathan P; Robson, Matthew J; Blakely, Randy D; Popovich, Phillip G; Bilbo, Staci D; Quan, Ning 2019. Cell-Type-Specific Interleukin 1 Receptor 1 Signaling in the Brain Regulates Distinct Neuroimmune Activities. Immunity, , Quinlan, Meagan A; Krout, Danielle; Katamish, Rania; Robson, Matthew J; Nettesheim, Catherine; Gresch, Paul J; Mash, Deborah; Henry, Keith; Blakely, Randy D 2019. Human Serotonin Transporter Coding Variation Establishes Conformational Bias with Functional Consequences. ACS chemical neuroscience, , Thome, Jason G; Reeder, Evan L; Collins, Sean M; Gopalan, Poornima; Robson, Matthew J 2019. Contributions of Interleukin-1 Receptor Signaling in Traumatic Brain Injury. Frontiers in behavioral neuroscience, 13 , 287Burke, Susan J; Batdorf, Heidi M; Burk, David H; Martin, Thomas M; Mendoza, Tamra; Stadler, Krisztian; Alami, Wateen; Karlstad, Michael D; Robson, Matthew J; Blakely, Randy D; Mynatt, Randall L; Collier, J Jason 2018. Pancreatic deletion of the interleukin-1 receptor disrupts whole body glucose homeostasis and promotes islet B-cell de-differentiation. Molecular metabolism, , Robson, Matthew J; Quinlan, Meagan A; Margolis, Kara Gross; Gajewski-Kurdziel, Paula A; Veenstra-VanderWeele, Jeremy; Gershon, Michael D; Watterson, D Martin; Blakely, Randy D 2018. p38a MAPK signaling drives pharmacologically reversible brain and gastrointestinal phenotypes in the SERT Ala56 mouse. Proceedings of the National Academy of Sciences of the United States of America, , Robson, Matthew J; Quinlan, Meagan A; Blakely, Randy D 2017. Immune System Activation and Depression: Roles of Serotonin in the Central Nervous System and Periphery. ACS chemical neuroscience, 8 5, 932-942Gengo, Fran; Westphal, Erica S; Rainka, Michelle M; Janda, Maria; Robson, Matthew J; Hourihane, J Maurice; Bates, Vernice 2016. Platelet response to increased aspirin dose in patients with persistent platelet aggregation while treated with aspirin 81?mg. Journal of clinical pharmacology, 56 4, 414-21Lucke-Wold, Brandon P; Turner, Ryan C; Logsdon, Aric F; Nguyen, Linda; Bailes, Julian E; Lee, John M; Robson, Matthew J; Omalu, Bennet I; Huber, Jason D; Rosen, Charles L 2016. Endoplasmic reticulum stress implicated in chronic traumatic encephalopathy. Journal of neurosurgery, 124 3, 687-702Robson, Matthew J; Zhu, Chong-Bin; Quinlan, Meagan A; Botschner, David A; Baganz, Nicole L; Lindler, Kathryn M; Thome, Jason G; Hewlett, William A; Blakely, Randy D 2016. Generation and Characterization of Mice Expressing a Conditional Allele of the Interleukin-1 Receptor Type 1. PloS one, 11 3, e0150068Turner, Ryan C; Lucke-Wold, Brandon P; Robson, Matthew J; Lee, John M; Bailes, Julian E 2016. Alzheimer's disease and chronic traumatic encephalopathy: Distinct but possibly overlapping disease entities. Brain injury, 30 11, 1279-1292Baganz, N L; Lindler, K M; Zhu, C B; Smith, J T; Robson, M J; Iwamoto, H; Deneris, E S; Hewlett, W A; Blakely, R D 2015. A requirement of serotonergic p38? mitogen-activated protein kinase for peripheral immune system activation of CNS serotonin uptake and serotonin-linked behaviors. Translational psychiatry, 5 , e671Lucke-Wold, Brandon P; Naser, Zachary J; Logsdon, Aric F; Turner, Ryan C; Smith, Kelly E; Robson, Matthew J; Bailes, Julian E; Lee, John M; Rosen, Charles L; Huber, Jason D 2015. Amelioration of nicotinamide adenine dinucleotide phosphate-oxidase mediated stress reduces cell death after blast-induced traumatic brain injury. Translational research : the journal of laboratory and clinical medicine, 166 6, 509-528.e1Nguyen, Linda; Lucke-Wold, Brandon P; Mookerjee, Shona A; Cavendish, John Z; Robson, Matthew J; Scandinaro, Anna L; Matsumoto, Rae R 2015. Role of sigma-1 receptors in neurodegenerative diseases. Journal of pharmacological sciences, 127 1, 17-29Turner, Ryan C; Lucke-Wold, Brandon P; Logsdon, Aric F; Robson, Matthew J; Dashnaw, Matthew L; Huang, Jason H; Smith, Kelly E; Huber, Jason D; Rosen, Charles L; Petraglia, Anthony L 2015. The Quest to Model Chronic Traumatic Encephalopathy: A Multiple Model and Injury Paradigm Experience. Frontiers in neurology, 6 , 222Turner, Ryan C; Lucke-Wold, Brandon P; Logsdon, Aric F; Robson, Matthew J; Lee, John M; Bailes, Julian E; Dashnaw, Matthew L; Huber, Jason D; Petraglia, Anthony L; Rosen, Charles L 2015. Modeling Chronic Traumatic Encephalopathy: The Way Forward for Future Discovery. Frontiers in neurology, 6 , 223Kaushal, Nidhi; Robson, Matthew J; Rosen, Abagail; McCurdy, Christopher R; Matsumoto, Rae R 2014. Neuroprotective targets through which 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), a sigma receptor ligand, mitigates the effects of methamphetamine in vitro. European journal of pharmacology, 724 , 193-203Logsdon, Aric Flint; Turner, Ryan Coddington; Lucke-Wold, Brandon Peter; Robson, Matthew James; Naser, Zachary James; Smith, Kelly Elizabeth; Matsumoto, Rae Reiko; Huber, Jason Delwyn; Rosen, Charles Lee 2014. Altering endoplasmic reticulum stress in a model of blast-induced traumatic brain injury controls cellular fate and ameliorates neuropsychiatric symptoms. Frontiers in cellular neuroscience, 8 , 421Matsumoto, Rae R; Nguyen, Linda; Kaushal, Nidhi; Robson, Matthew J 2014. Sigma (?) receptors as potential therapeutic targets to mitigate psychostimulant effects. Advances in pharmacology (San Diego, Calif.), 69 , 323-86Matsumoto, Rae R; Seminerio, Michael J; Turner, Ryan C; Robson, Matthew J; Nguyen, Linda; Miller, Diane B; O'Callaghan, James P 2014. Methamphetamine-induced toxicity: an updated review on issues related to hyperthermia. Pharmacology & therapeutics, 144 1, 28-40Nguyen, Linda; Kaushal, Nidhi; Robson, Matthew J; Matsumoto, Rae R 2014. Sigma receptors as potential therapeutic targets for neuroprotection. European journal of pharmacology, 743 , 42-7Nguyen, Linda; Robson, Matthew J; Healy, Jason R; Scandinaro, Anna L; Matsumoto, Rae R 2014. Involvement of sigma-1 receptors in the antidepressant-like effects of dextromethorphan. PloS one, 9 2, e89985Robson, Matthew J; Turner, Ryan C; Naser, Zachary J; McCurdy, Christopher R; O'Callaghan, James P; Huber, Jason D; Matsumoto, Rae R 2014. SN79, a sigma receptor antagonist, attenuates methamphetamine-induced astrogliosis through a blockade of OSMR/gp130 signaling and STAT3 phosphorylation. Experimental neurology, 254 , 180-9Kaushal, Nidhi; Seminerio, Michael J; Robson, Matthew J; McCurdy, Christopher R; Matsumoto, Rae R 2013. Pharmacological evaluation of SN79, a sigma (?) receptor ligand, against methamphetamine-induced neurotoxicity in vivo. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 23 8, 960-71Robson, Matthew J; Seminerio, Michael J; McCurdy, Christopher R; Coop, Andrew; Matsumoto, Rae R 2013. ? Receptor antagonist attenuation of methamphetamine-induced neurotoxicity is correlated to body temperature modulation. Pharmacological reports : PR, 65 2, 343-9Robson, Matthew J; Turner, Ryan C; Naser, Zachary J; McCurdy, Christopher R; Huber, Jason D; Matsumoto, Rae R 2013. SN79, a sigma receptor ligand, blocks methamphetamine-induced microglial activation and cytokine upregulation. Experimental neurology, 247 , 134-42Turner, Ryan C; Naser, Zachary J; Logsdon, Aric F; DiPasquale, Kenneth H; Jackson, Garrett J; Robson, Matthew J; Gettens, Robert T T; Matsumoto, Rae R; Huber, Jason D; Rosen, Charles L 2013. Modeling clinically relevant blast parameters based on scaling principles produces functional & histological deficits in rats. Experimental neurology, 248 , 520-9Kaushal, Nidhi; Elliott, Meenal; Robson, Matthew J; Iyer, Anand Krishnan V; Rojanasakul, Yon; Coop, Andrew; Matsumoto, Rae R 2012. AC927, a ? receptor ligand, blocks methamphetamine-induced release of dopamine and generation of reactive oxygen species in NG108-15 cells. Molecular pharmacology, 81 3, 299-308Robson, Matthew J; Elliott, Meenal; Seminerio, Michael J; Matsumoto, Rae R 2012. Evaluation of sigma (?) receptors in the antidepressant-like effects of ketamine in vitro and in vivo. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 22 4, 308-17Robson, Matthew J; Noorbakhsh, Bahar; Seminerio, Michael J; Matsumoto, Rae R 2012. Sigma-1 receptors: potential targets for the treatment of substance abuse. Current pharmaceutical design, 18 7, 902-19Seminerio, Michael J; Robson, Matthew J; Abdelazeem, Ahmed H; Mesangeau, Christophe; Jamalapuram, Seshulatha; Avery, Bonnie A; McCurdy, Christopher R; Matsumoto, Rae R 2012. Synthesis and pharmacological characterization of a novel sigma receptor ligand with improved metabolic stability and antagonistic effects against methamphetamine. The AAPS journal, 14 1, 43-51Seminerio, Michael J; Robson, Matthew J; McCurdy, Christopher R; Matsumoto, Rae R 2012. Sigma receptor antagonists attenuate acute methamphetamine-induced hyperthermia by a mechanism independent of IL-1? mRNA expression in the hypothalamus. European journal of pharmacology, 691 1-3, 103-9Turner, Ryan C; Lucke-Wold, Brandon P; Robson, Matthew J; Omalu, Bennet I; Petraglia, Anthony L; Bailes, Julian E 2012. Repetitive traumatic brain injury and development of chronic traumatic encephalopathy: a potential role for biomarkers in diagnosis, prognosis, and treatment? Frontiers in neurology, 3 , 186Xu, Yan-Tong; Robson, Matthew J; Szeszel-Fedorowicz, Wioletta; Patel, Divyen; Rooney, Robert; McCurdy, Christopher R; Matsumoto, Rae R 2012. CM156, a sigma receptor ligand, reverses cocaine-induced place conditioning and transcriptional responses in the brain. Pharmacology, biochemistry, and behavior, 101 1, 174-80Kaushal, Nidhi; Robson, Matthew J; Vinnakota, Harsha; Narayanan, Sanju; Avery, Bonnie A; McCurdy, Christopher R; Matsumoto, Rae R 2011. Synthesis and pharmacological evaluation of 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), a cocaine antagonist, in rodents. The AAPS journal, 13 3, 336-46Fishback, James A; Robson, Matthew J; Xu, Yan-Tong; Matsumoto, Rae R 2010. Sigma receptors: potential targets for a new class of antidepressant drug. Pharmacology & therapeutics, 127 3, 271-82Gengo, Francis M; Rainka, Michelle; Robson, Matthew; Gengo, Michael F; Forrest, Alan; Hourihane, Maurice; Bates, Vernice 2008. Prevalence of platelet nonresponsiveness to aspirin in patients treated for secondary stroke prophylaxis and in patients with recurrent ischemic events. Journal of clinical pharmacology, 48 3, 335-43
Research InterestsTraumatic brain injuries (TBI) are a leading cause of disability in populations across the globe. Diverse environmental factors can lead to various forms of TBI, many of which result in the generation of chronic, neuropsychiatric comorbitidies such as depression, anxiety and social withdrawal. Our current understanding of the neuronal and molecular mechanisms that contribute to the generation of these neuropsychiatric complications remains limited. The focus of the Robson Laboratory is to enhance ou...
Peer Reviewed Publications Chen, Yanting; Lu, Xiaohan; Whitney, Raeann L; Li, Yu; Robson, Matthew J; Blakely, Randy D; Chi, Jen-Tsan; Crowley, Steven D; Privratsky, Jamie R 2024. Novel anti-inflammatory effects of the IL-1 receptor in kidney myeloid cells following ischemic AKI. Frontiers in molecular biosciences, 11 , 1366259Hetzer, S M; O'Connell, C; Lallo, V; Robson, M; Evanson, N K 2024. Model matters: Differential outcomes in traumatic optic neuropathy pathophysiology between blunt and blast-wave mediated head injuries. Experimental neurology, 372 , 114613O'Connell, Christopher J; Brown, Ryan S; Peach, Taylor M; Traubert, Owen D; Schwierling, Hana C; Notorgiacomo, Gabrielle A; Robson, Matthew J 2024. Strain in the Midbrain: Impact of Traumatic Brain Injury on the Central Serotonin System. Brain sciences, 14 1, O'Connell, Christopher J; Reeder, Evan L; Hymore, Jacob A; Brown, Ryan S; Notorgiacomo, Gabrielle A; Collins, Sean M; Gudelsky, Gary A; Robson, Matthew J 2024. Transcriptomic dynamics governing serotonergic dysregulation in the dorsal raphe nucleus following mild traumatic brain injury. Experimental neurology, 374 , 114695Luis, Tiago C; Barkas, Nikolaos; Carrelha, Joana; Giustacchini, Alice; Mazzi, Stefania; Norfo, Ruggiero; Wu, Bishan; Aliouat, Affaf; Guerrero, Jose A; Rodriguez-Meira, Alba; Bouriez-Jones, Tiphaine; Macaulay, Iain C; Jasztal, Maria; Zhu, Guangheng; Ni, Heyu; Robson, Matthew J; Blakely, Randy D; Mead, Adam J; Nerlov, Claus; Ghevaert, Cedric; Jacobsen, Sten Eirik W 2023. Perivascular niche cells sense thrombocytopenia and activate hematopoietic stem cells in an IL-1 dependent manner. Nature communications, 14 1, 6062Reeder, Evan L; O'Connell, Christopher J; Collins, Sean M; Traubert, Owen D; Norman, Sophia V; Cáceres, Román A; Sah, Renu; Smith, David W; Robson, Matthew J 2023. Increased Carbon Dioxide Respiration Prevents the Effects of Acceleration/Deceleration Elicited Mild Traumatic Brain Injury. Neuroscience, 509 , 20-35Ren, Jiafa; Liu, Kang; Wu, Buyun; Lu, Xiaohan; Sun, Lianqin; Privratsky, Jamie R; Xing, Changying; Robson, Matthew J; Mao, Huijuan; Blakely, Randy D; Abe, Koki; Souma, Tomokazu; Crowley, Steven D 2023. Divergent Actions of Renal Tubular and Endothelial Type 1 IL-1 Receptor Signaling in Toxin-Induced AKI. Journal of the American Society of Nephrology : JASN, 34 10, 1629-1646Singer, Kathleen E; McGlone, Emily D; Collins, Sean M; Wallen, Taylor E; Morris, Mackenzie C; Schuster, Rebecca M; England, Lisa G; Robson, Matthew J; Goodman, Michael D 2023. Propranolol Reduces p-tau Accumulation and Improves Behavior Outcomes in a Polytrauma Murine Model. The Journal of surgical research, 282 , 183-190Collins, Sean M; O'Connell, Christopher J; Reeder, Evan L; Norman, Sophia V; Lungani, Kainat; Gopalan, Poornima; Gudelsky, Gary A; Robson, Matthew J 2022. Altered Serotonin 2A (5-HT2A) Receptor Signaling Underlies Mild TBI-Elicited Deficits in Social Dominance. Frontiers in pharmacology, 13 , 930346O'Connell, Christopher J; Reeder, Evan L; Collins, Sean M; Lungani, Kainat; Norman, Sophia V; Robson, Matthew J 2022. Mild traumatic brain injury elicits time- and region-specific reductions in serotonin transporter protein expression and uptake capacity. Neuroreport, 33 14, 612-616Reeder, Evan L; Liber, Mei-Ling; Traubert, Owen D; O'Connell, Christopher J; Turner, Ryan C; Robson, Matthew J 2022. Effect of driver gas composition on production of scaled Friedlander waveforms in an open-ended shock tube model. Biomedical physics & engineering express, 8 6, Ren, Jiafa; Lu, Xiaohan; Hall, Gentzon; Privratsky, Jamie R; Robson, Matthew J; Blakely, Randy D; Crowley, Steven D 2022. IL-1 receptor signaling in podocytes limits susceptibility to glomerular damage. American journal of physiology. Renal physiology, 322 2, F164-F174Logsdon, Aric F; Lucke-Wold, Brandon P; Turner, Ryan C; Collins, Sean M; Reeder, Evan L; Huber, Jason D; Rosen, Charles L; Robson, Matthew J; Plattner, Florian 2020. Low-intensity Blast Wave Model for Preclinical Assessment of Closed-head Mild Traumatic Brain Injury in Rodents. Journal of visualized experiments : JoVE, 165, Quinlan, Meagan A; Robson, Matthew J; Ye, Ran; Rose, Kristie L; Schey, Kevin L; Blakely, Randy D 2020. Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant. Frontiers in molecular neuroscience, 13 , 89Sturchio, Andrea; Marsili, Luca; Vizcarra, Joaquin A; Dwivedi, Alok K; Kauffman, Marcelo A; Duker, Andrew P; Lu, Peixin; Pauciulo, Michael W; Wissel, Benjamin D; Hill, Emily J; Stecher, Benjamin; Keeling, Elizabeth G; Vagal, Achala S; Wang, Lily; Haslam, David B; Robson, Matthew J; Tanner, Caroline M; Hagey, Daniel W; El Andaloussi, Samir; Ezzat, Kariem; Fleming, Ronan M T; Lu, Long J; Little, Max A; Espay, Alberto J 2020. Phenotype-Agnostic Molecular Subtyping of Neurodegenerative Disorders: The Cincinnati Cohort Biomarker Program (CCBP). Frontiers in aging neuroscience, 12 , 553635Khalid, Fatima; Yang, George L; McGuire, Jennifer L; Robson, Matthew J; Foreman, Brandon; Ngwenya, Laura B; Lorenz, John N 2019. Autonomic dysfunction following traumatic brain injury: translational insights. Neurosurgical focus, 47 5, E8Liu, Xiaoyu; Nemeth, Daniel P; McKim, Daniel B; Zhu, Ling; DiSabato, Damon J; Berdysz, Olimpia; Gorantla, Gowthami; Oliver, Braedan; Witcher, Kristina G; Wang, Yufen; Negray, Christina E; Vegesna, Rekha S; Sheridan, John F; Godbout, Jonathan P; Robson, Matthew J; Blakely, Randy D; Popovich, Phillip G; Bilbo, Staci D; Quan, Ning 2019. Cell-Type-Specific Interleukin 1 Receptor 1 Signaling in the Brain Regulates Distinct Neuroimmune Activities. Immunity, , Quinlan, Meagan A; Krout, Danielle; Katamish, Rania; Robson, Matthew J; Nettesheim, Catherine; Gresch, Paul J; Mash, Deborah; Henry, Keith; Blakely, Randy D 2019. Human Serotonin Transporter Coding Variation Establishes Conformational Bias with Functional Consequences. ACS chemical neuroscience, , Thome, Jason G; Reeder, Evan L; Collins, Sean M; Gopalan, Poornima; Robson, Matthew J 2019. Contributions of Interleukin-1 Receptor Signaling in Traumatic Brain Injury. Frontiers in behavioral neuroscience, 13 , 287Burke, Susan J; Batdorf, Heidi M; Burk, David H; Martin, Thomas M; Mendoza, Tamra; Stadler, Krisztian; Alami, Wateen; Karlstad, Michael D; Robson, Matthew J; Blakely, Randy D; Mynatt, Randall L; Collier, J Jason 2018. Pancreatic deletion of the interleukin-1 receptor disrupts whole body glucose homeostasis and promotes islet B-cell de-differentiation. Molecular metabolism, , Robson, Matthew J; Quinlan, Meagan A; Margolis, Kara Gross; Gajewski-Kurdziel, Paula A; Veenstra-VanderWeele, Jeremy; Gershon, Michael D; Watterson, D Martin; Blakely, Randy D 2018. p38a MAPK signaling drives pharmacologically reversible brain and gastrointestinal phenotypes in the SERT Ala56 mouse. Proceedings of the National Academy of Sciences of the United States of America, , Robson, Matthew J; Quinlan, Meagan A; Blakely, Randy D 2017. Immune System Activation and Depression: Roles of Serotonin in the Central Nervous System and Periphery. ACS chemical neuroscience, 8 5, 932-942Gengo, Fran; Westphal, Erica S; Rainka, Michelle M; Janda, Maria; Robson, Matthew J; Hourihane, J Maurice; Bates, Vernice 2016. Platelet response to increased aspirin dose in patients with persistent platelet aggregation while treated with aspirin 81?mg. Journal of clinical pharmacology, 56 4, 414-21Lucke-Wold, Brandon P; Turner, Ryan C; Logsdon, Aric F; Nguyen, Linda; Bailes, Julian E; Lee, John M; Robson, Matthew J; Omalu, Bennet I; Huber, Jason D; Rosen, Charles L 2016. Endoplasmic reticulum stress implicated in chronic traumatic encephalopathy. Journal of neurosurgery, 124 3, 687-702Robson, Matthew J; Zhu, Chong-Bin; Quinlan, Meagan A; Botschner, David A; Baganz, Nicole L; Lindler, Kathryn M; Thome, Jason G; Hewlett, William A; Blakely, Randy D 2016. Generation and Characterization of Mice Expressing a Conditional Allele of the Interleukin-1 Receptor Type 1. PloS one, 11 3, e0150068Turner, Ryan C; Lucke-Wold, Brandon P; Robson, Matthew J; Lee, John M; Bailes, Julian E 2016. Alzheimer's disease and chronic traumatic encephalopathy: Distinct but possibly overlapping disease entities. Brain injury, 30 11, 1279-1292Baganz, N L; Lindler, K M; Zhu, C B; Smith, J T; Robson, M J; Iwamoto, H; Deneris, E S; Hewlett, W A; Blakely, R D 2015. A requirement of serotonergic p38? mitogen-activated protein kinase for peripheral immune system activation of CNS serotonin uptake and serotonin-linked behaviors. Translational psychiatry, 5 , e671Lucke-Wold, Brandon P; Naser, Zachary J; Logsdon, Aric F; Turner, Ryan C; Smith, Kelly E; Robson, Matthew J; Bailes, Julian E; Lee, John M; Rosen, Charles L; Huber, Jason D 2015. Amelioration of nicotinamide adenine dinucleotide phosphate-oxidase mediated stress reduces cell death after blast-induced traumatic brain injury. Translational research : the journal of laboratory and clinical medicine, 166 6, 509-528.e1Nguyen, Linda; Lucke-Wold, Brandon P; Mookerjee, Shona A; Cavendish, John Z; Robson, Matthew J; Scandinaro, Anna L; Matsumoto, Rae R 2015. Role of sigma-1 receptors in neurodegenerative diseases. Journal of pharmacological sciences, 127 1, 17-29Turner, Ryan C; Lucke-Wold, Brandon P; Logsdon, Aric F; Robson, Matthew J; Dashnaw, Matthew L; Huang, Jason H; Smith, Kelly E; Huber, Jason D; Rosen, Charles L; Petraglia, Anthony L 2015. The Quest to Model Chronic Traumatic Encephalopathy: A Multiple Model and Injury Paradigm Experience. Frontiers in neurology, 6 , 222Turner, Ryan C; Lucke-Wold, Brandon P; Logsdon, Aric F; Robson, Matthew J; Lee, John M; Bailes, Julian E; Dashnaw, Matthew L; Huber, Jason D; Petraglia, Anthony L; Rosen, Charles L 2015. Modeling Chronic Traumatic Encephalopathy: The Way Forward for Future Discovery. Frontiers in neurology, 6 , 223Kaushal, Nidhi; Robson, Matthew J; Rosen, Abagail; McCurdy, Christopher R; Matsumoto, Rae R 2014. Neuroprotective targets through which 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), a sigma receptor ligand, mitigates the effects of methamphetamine in vitro. European journal of pharmacology, 724 , 193-203Logsdon, Aric Flint; Turner, Ryan Coddington; Lucke-Wold, Brandon Peter; Robson, Matthew James; Naser, Zachary James; Smith, Kelly Elizabeth; Matsumoto, Rae Reiko; Huber, Jason Delwyn; Rosen, Charles Lee 2014. Altering endoplasmic reticulum stress in a model of blast-induced traumatic brain injury controls cellular fate and ameliorates neuropsychiatric symptoms. Frontiers in cellular neuroscience, 8 , 421Matsumoto, Rae R; Nguyen, Linda; Kaushal, Nidhi; Robson, Matthew J 2014. Sigma (?) receptors as potential therapeutic targets to mitigate psychostimulant effects. Advances in pharmacology (San Diego, Calif.), 69 , 323-86Matsumoto, Rae R; Seminerio, Michael J; Turner, Ryan C; Robson, Matthew J; Nguyen, Linda; Miller, Diane B; O'Callaghan, James P 2014. Methamphetamine-induced toxicity: an updated review on issues related to hyperthermia. Pharmacology & therapeutics, 144 1, 28-40Nguyen, Linda; Kaushal, Nidhi; Robson, Matthew J; Matsumoto, Rae R 2014. Sigma receptors as potential therapeutic targets for neuroprotection. European journal of pharmacology, 743 , 42-7Nguyen, Linda; Robson, Matthew J; Healy, Jason R; Scandinaro, Anna L; Matsumoto, Rae R 2014. Involvement of sigma-1 receptors in the antidepressant-like effects of dextromethorphan. PloS one, 9 2, e89985Robson, Matthew J; Turner, Ryan C; Naser, Zachary J; McCurdy, Christopher R; O'Callaghan, James P; Huber, Jason D; Matsumoto, Rae R 2014. SN79, a sigma receptor antagonist, attenuates methamphetamine-induced astrogliosis through a blockade of OSMR/gp130 signaling and STAT3 phosphorylation. Experimental neurology, 254 , 180-9Kaushal, Nidhi; Seminerio, Michael J; Robson, Matthew J; McCurdy, Christopher R; Matsumoto, Rae R 2013. Pharmacological evaluation of SN79, a sigma (?) receptor ligand, against methamphetamine-induced neurotoxicity in vivo. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 23 8, 960-71Robson, Matthew J; Seminerio, Michael J; McCurdy, Christopher R; Coop, Andrew; Matsumoto, Rae R 2013. ? Receptor antagonist attenuation of methamphetamine-induced neurotoxicity is correlated to body temperature modulation. Pharmacological reports : PR, 65 2, 343-9Robson, Matthew J; Turner, Ryan C; Naser, Zachary J; McCurdy, Christopher R; Huber, Jason D; Matsumoto, Rae R 2013. SN79, a sigma receptor ligand, blocks methamphetamine-induced microglial activation and cytokine upregulation. Experimental neurology, 247 , 134-42Turner, Ryan C; Naser, Zachary J; Logsdon, Aric F; DiPasquale, Kenneth H; Jackson, Garrett J; Robson, Matthew J; Gettens, Robert T T; Matsumoto, Rae R; Huber, Jason D; Rosen, Charles L 2013. Modeling clinically relevant blast parameters based on scaling principles produces functional & histological deficits in rats. Experimental neurology, 248 , 520-9Kaushal, Nidhi; Elliott, Meenal; Robson, Matthew J; Iyer, Anand Krishnan V; Rojanasakul, Yon; Coop, Andrew; Matsumoto, Rae R 2012. AC927, a ? receptor ligand, blocks methamphetamine-induced release of dopamine and generation of reactive oxygen species in NG108-15 cells. Molecular pharmacology, 81 3, 299-308Robson, Matthew J; Elliott, Meenal; Seminerio, Michael J; Matsumoto, Rae R 2012. Evaluation of sigma (?) receptors in the antidepressant-like effects of ketamine in vitro and in vivo. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 22 4, 308-17Robson, Matthew J; Noorbakhsh, Bahar; Seminerio, Michael J; Matsumoto, Rae R 2012. Sigma-1 receptors: potential targets for the treatment of substance abuse. Current pharmaceutical design, 18 7, 902-19Seminerio, Michael J; Robson, Matthew J; Abdelazeem, Ahmed H; Mesangeau, Christophe; Jamalapuram, Seshulatha; Avery, Bonnie A; McCurdy, Christopher R; Matsumoto, Rae R 2012. Synthesis and pharmacological characterization of a novel sigma receptor ligand with improved metabolic stability and antagonistic effects against methamphetamine. The AAPS journal, 14 1, 43-51Seminerio, Michael J; Robson, Matthew J; McCurdy, Christopher R; Matsumoto, Rae R 2012. Sigma receptor antagonists attenuate acute methamphetamine-induced hyperthermia by a mechanism independent of IL-1? mRNA expression in the hypothalamus. European journal of pharmacology, 691 1-3, 103-9Turner, Ryan C; Lucke-Wold, Brandon P; Robson, Matthew J; Omalu, Bennet I; Petraglia, Anthony L; Bailes, Julian E 2012. Repetitive traumatic brain injury and development of chronic traumatic encephalopathy: a potential role for biomarkers in diagnosis, prognosis, and treatment? Frontiers in neurology, 3 , 186Xu, Yan-Tong; Robson, Matthew J; Szeszel-Fedorowicz, Wioletta; Patel, Divyen; Rooney, Robert; McCurdy, Christopher R; Matsumoto, Rae R 2012. CM156, a sigma receptor ligand, reverses cocaine-induced place conditioning and transcriptional responses in the brain. Pharmacology, biochemistry, and behavior, 101 1, 174-80Kaushal, Nidhi; Robson, Matthew J; Vinnakota, Harsha; Narayanan, Sanju; Avery, Bonnie A; McCurdy, Christopher R; Matsumoto, Rae R 2011. Synthesis and pharmacological evaluation of 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), a cocaine antagonist, in rodents. The AAPS journal, 13 3, 336-46Fishback, James A; Robson, Matthew J; Xu, Yan-Tong; Matsumoto, Rae R 2010. Sigma receptors: potential targets for a new class of antidepressant drug. Pharmacology & therapeutics, 127 3, 271-82Gengo, Francis M; Rainka, Michelle; Robson, Matthew; Gengo, Michael F; Forrest, Alan; Hourihane, Maurice; Bates, Vernice 2008. Prevalence of platelet nonresponsiveness to aspirin in patients treated for secondary stroke prophylaxis and in patients with recurrent ischemic events. Journal of clinical pharmacology, 48 3, 335-43
Chen, Yanting; Lu, Xiaohan; Whitney, Raeann L; Li, Yu; Robson, Matthew J; Blakely, Randy D; Chi, Jen-Tsan; Crowley, Steven D; Privratsky, Jamie R 2024. Novel anti-inflammatory effects of the IL-1 receptor in kidney myeloid cells following ischemic AKI. Frontiers in molecular biosciences, 11 , 1366259Hetzer, S M; O'Connell, C; Lallo, V; Robson, M; Evanson, N K 2024. Model matters: Differential outcomes in traumatic optic neuropathy pathophysiology between blunt and blast-wave mediated head injuries. Experimental neurology, 372 , 114613O'Connell, Christopher J; Brown, Ryan S; Peach, Taylor M; Traubert, Owen D; Schwierling, Hana C; Notorgiacomo, Gabrielle A; Robson, Matthew J 2024. Strain in the Midbrain: Impact of Traumatic Brain Injury on the Central Serotonin System. Brain sciences, 14 1, O'Connell, Christopher J; Reeder, Evan L; Hymore, Jacob A; Brown, Ryan S; Notorgiacomo, Gabrielle A; Collins, Sean M; Gudelsky, Gary A; Robson, Matthew J 2024. Transcriptomic dynamics governing serotonergic dysregulation in the dorsal raphe nucleus following mild traumatic brain injury. Experimental neurology, 374 , 114695Luis, Tiago C; Barkas, Nikolaos; Carrelha, Joana; Giustacchini, Alice; Mazzi, Stefania; Norfo, Ruggiero; Wu, Bishan; Aliouat, Affaf; Guerrero, Jose A; Rodriguez-Meira, Alba; Bouriez-Jones, Tiphaine; Macaulay, Iain C; Jasztal, Maria; Zhu, Guangheng; Ni, Heyu; Robson, Matthew J; Blakely, Randy D; Mead, Adam J; Nerlov, Claus; Ghevaert, Cedric; Jacobsen, Sten Eirik W 2023. Perivascular niche cells sense thrombocytopenia and activate hematopoietic stem cells in an IL-1 dependent manner. Nature communications, 14 1, 6062Reeder, Evan L; O'Connell, Christopher J; Collins, Sean M; Traubert, Owen D; Norman, Sophia V; Cáceres, Román A; Sah, Renu; Smith, David W; Robson, Matthew J 2023. Increased Carbon Dioxide Respiration Prevents the Effects of Acceleration/Deceleration Elicited Mild Traumatic Brain Injury. Neuroscience, 509 , 20-35Ren, Jiafa; Liu, Kang; Wu, Buyun; Lu, Xiaohan; Sun, Lianqin; Privratsky, Jamie R; Xing, Changying; Robson, Matthew J; Mao, Huijuan; Blakely, Randy D; Abe, Koki; Souma, Tomokazu; Crowley, Steven D 2023. Divergent Actions of Renal Tubular and Endothelial Type 1 IL-1 Receptor Signaling in Toxin-Induced AKI. Journal of the American Society of Nephrology : JASN, 34 10, 1629-1646Singer, Kathleen E; McGlone, Emily D; Collins, Sean M; Wallen, Taylor E; Morris, Mackenzie C; Schuster, Rebecca M; England, Lisa G; Robson, Matthew J; Goodman, Michael D 2023. Propranolol Reduces p-tau Accumulation and Improves Behavior Outcomes in a Polytrauma Murine Model. The Journal of surgical research, 282 , 183-190Collins, Sean M; O'Connell, Christopher J; Reeder, Evan L; Norman, Sophia V; Lungani, Kainat; Gopalan, Poornima; Gudelsky, Gary A; Robson, Matthew J 2022. Altered Serotonin 2A (5-HT2A) Receptor Signaling Underlies Mild TBI-Elicited Deficits in Social Dominance. Frontiers in pharmacology, 13 , 930346O'Connell, Christopher J; Reeder, Evan L; Collins, Sean M; Lungani, Kainat; Norman, Sophia V; Robson, Matthew J 2022. Mild traumatic brain injury elicits time- and region-specific reductions in serotonin transporter protein expression and uptake capacity. Neuroreport, 33 14, 612-616Reeder, Evan L; Liber, Mei-Ling; Traubert, Owen D; O'Connell, Christopher J; Turner, Ryan C; Robson, Matthew J 2022. Effect of driver gas composition on production of scaled Friedlander waveforms in an open-ended shock tube model. Biomedical physics & engineering express, 8 6, Ren, Jiafa; Lu, Xiaohan; Hall, Gentzon; Privratsky, Jamie R; Robson, Matthew J; Blakely, Randy D; Crowley, Steven D 2022. IL-1 receptor signaling in podocytes limits susceptibility to glomerular damage. American journal of physiology. Renal physiology, 322 2, F164-F174Logsdon, Aric F; Lucke-Wold, Brandon P; Turner, Ryan C; Collins, Sean M; Reeder, Evan L; Huber, Jason D; Rosen, Charles L; Robson, Matthew J; Plattner, Florian 2020. Low-intensity Blast Wave Model for Preclinical Assessment of Closed-head Mild Traumatic Brain Injury in Rodents. Journal of visualized experiments : JoVE, 165, Quinlan, Meagan A; Robson, Matthew J; Ye, Ran; Rose, Kristie L; Schey, Kevin L; Blakely, Randy D 2020. Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant. Frontiers in molecular neuroscience, 13 , 89Sturchio, Andrea; Marsili, Luca; Vizcarra, Joaquin A; Dwivedi, Alok K; Kauffman, Marcelo A; Duker, Andrew P; Lu, Peixin; Pauciulo, Michael W; Wissel, Benjamin D; Hill, Emily J; Stecher, Benjamin; Keeling, Elizabeth G; Vagal, Achala S; Wang, Lily; Haslam, David B; Robson, Matthew J; Tanner, Caroline M; Hagey, Daniel W; El Andaloussi, Samir; Ezzat, Kariem; Fleming, Ronan M T; Lu, Long J; Little, Max A; Espay, Alberto J 2020. Phenotype-Agnostic Molecular Subtyping of Neurodegenerative Disorders: The Cincinnati Cohort Biomarker Program (CCBP). Frontiers in aging neuroscience, 12 , 553635Khalid, Fatima; Yang, George L; McGuire, Jennifer L; Robson, Matthew J; Foreman, Brandon; Ngwenya, Laura B; Lorenz, John N 2019. Autonomic dysfunction following traumatic brain injury: translational insights. Neurosurgical focus, 47 5, E8Liu, Xiaoyu; Nemeth, Daniel P; McKim, Daniel B; Zhu, Ling; DiSabato, Damon J; Berdysz, Olimpia; Gorantla, Gowthami; Oliver, Braedan; Witcher, Kristina G; Wang, Yufen; Negray, Christina E; Vegesna, Rekha S; Sheridan, John F; Godbout, Jonathan P; Robson, Matthew J; Blakely, Randy D; Popovich, Phillip G; Bilbo, Staci D; Quan, Ning 2019. Cell-Type-Specific Interleukin 1 Receptor 1 Signaling in the Brain Regulates Distinct Neuroimmune Activities. Immunity, , Quinlan, Meagan A; Krout, Danielle; Katamish, Rania; Robson, Matthew J; Nettesheim, Catherine; Gresch, Paul J; Mash, Deborah; Henry, Keith; Blakely, Randy D 2019. Human Serotonin Transporter Coding Variation Establishes Conformational Bias with Functional Consequences. ACS chemical neuroscience, , Thome, Jason G; Reeder, Evan L; Collins, Sean M; Gopalan, Poornima; Robson, Matthew J 2019. Contributions of Interleukin-1 Receptor Signaling in Traumatic Brain Injury. Frontiers in behavioral neuroscience, 13 , 287Burke, Susan J; Batdorf, Heidi M; Burk, David H; Martin, Thomas M; Mendoza, Tamra; Stadler, Krisztian; Alami, Wateen; Karlstad, Michael D; Robson, Matthew J; Blakely, Randy D; Mynatt, Randall L; Collier, J Jason 2018. Pancreatic deletion of the interleukin-1 receptor disrupts whole body glucose homeostasis and promotes islet B-cell de-differentiation. Molecular metabolism, , Robson, Matthew J; Quinlan, Meagan A; Margolis, Kara Gross; Gajewski-Kurdziel, Paula A; Veenstra-VanderWeele, Jeremy; Gershon, Michael D; Watterson, D Martin; Blakely, Randy D 2018. p38a MAPK signaling drives pharmacologically reversible brain and gastrointestinal phenotypes in the SERT Ala56 mouse. Proceedings of the National Academy of Sciences of the United States of America, , Robson, Matthew J; Quinlan, Meagan A; Blakely, Randy D 2017. Immune System Activation and Depression: Roles of Serotonin in the Central Nervous System and Periphery. ACS chemical neuroscience, 8 5, 932-942Gengo, Fran; Westphal, Erica S; Rainka, Michelle M; Janda, Maria; Robson, Matthew J; Hourihane, J Maurice; Bates, Vernice 2016. Platelet response to increased aspirin dose in patients with persistent platelet aggregation while treated with aspirin 81?mg. Journal of clinical pharmacology, 56 4, 414-21Lucke-Wold, Brandon P; Turner, Ryan C; Logsdon, Aric F; Nguyen, Linda; Bailes, Julian E; Lee, John M; Robson, Matthew J; Omalu, Bennet I; Huber, Jason D; Rosen, Charles L 2016. Endoplasmic reticulum stress implicated in chronic traumatic encephalopathy. Journal of neurosurgery, 124 3, 687-702Robson, Matthew J; Zhu, Chong-Bin; Quinlan, Meagan A; Botschner, David A; Baganz, Nicole L; Lindler, Kathryn M; Thome, Jason G; Hewlett, William A; Blakely, Randy D 2016. Generation and Characterization of Mice Expressing a Conditional Allele of the Interleukin-1 Receptor Type 1. PloS one, 11 3, e0150068Turner, Ryan C; Lucke-Wold, Brandon P; Robson, Matthew J; Lee, John M; Bailes, Julian E 2016. Alzheimer's disease and chronic traumatic encephalopathy: Distinct but possibly overlapping disease entities. Brain injury, 30 11, 1279-1292Baganz, N L; Lindler, K M; Zhu, C B; Smith, J T; Robson, M J; Iwamoto, H; Deneris, E S; Hewlett, W A; Blakely, R D 2015. A requirement of serotonergic p38? mitogen-activated protein kinase for peripheral immune system activation of CNS serotonin uptake and serotonin-linked behaviors. Translational psychiatry, 5 , e671Lucke-Wold, Brandon P; Naser, Zachary J; Logsdon, Aric F; Turner, Ryan C; Smith, Kelly E; Robson, Matthew J; Bailes, Julian E; Lee, John M; Rosen, Charles L; Huber, Jason D 2015. Amelioration of nicotinamide adenine dinucleotide phosphate-oxidase mediated stress reduces cell death after blast-induced traumatic brain injury. Translational research : the journal of laboratory and clinical medicine, 166 6, 509-528.e1Nguyen, Linda; Lucke-Wold, Brandon P; Mookerjee, Shona A; Cavendish, John Z; Robson, Matthew J; Scandinaro, Anna L; Matsumoto, Rae R 2015. Role of sigma-1 receptors in neurodegenerative diseases. Journal of pharmacological sciences, 127 1, 17-29Turner, Ryan C; Lucke-Wold, Brandon P; Logsdon, Aric F; Robson, Matthew J; Dashnaw, Matthew L; Huang, Jason H; Smith, Kelly E; Huber, Jason D; Rosen, Charles L; Petraglia, Anthony L 2015. The Quest to Model Chronic Traumatic Encephalopathy: A Multiple Model and Injury Paradigm Experience. Frontiers in neurology, 6 , 222Turner, Ryan C; Lucke-Wold, Brandon P; Logsdon, Aric F; Robson, Matthew J; Lee, John M; Bailes, Julian E; Dashnaw, Matthew L; Huber, Jason D; Petraglia, Anthony L; Rosen, Charles L 2015. Modeling Chronic Traumatic Encephalopathy: The Way Forward for Future Discovery. Frontiers in neurology, 6 , 223Kaushal, Nidhi; Robson, Matthew J; Rosen, Abagail; McCurdy, Christopher R; Matsumoto, Rae R 2014. Neuroprotective targets through which 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), a sigma receptor ligand, mitigates the effects of methamphetamine in vitro. European journal of pharmacology, 724 , 193-203Logsdon, Aric Flint; Turner, Ryan Coddington; Lucke-Wold, Brandon Peter; Robson, Matthew James; Naser, Zachary James; Smith, Kelly Elizabeth; Matsumoto, Rae Reiko; Huber, Jason Delwyn; Rosen, Charles Lee 2014. Altering endoplasmic reticulum stress in a model of blast-induced traumatic brain injury controls cellular fate and ameliorates neuropsychiatric symptoms. Frontiers in cellular neuroscience, 8 , 421Matsumoto, Rae R; Nguyen, Linda; Kaushal, Nidhi; Robson, Matthew J 2014. Sigma (?) receptors as potential therapeutic targets to mitigate psychostimulant effects. Advances in pharmacology (San Diego, Calif.), 69 , 323-86Matsumoto, Rae R; Seminerio, Michael J; Turner, Ryan C; Robson, Matthew J; Nguyen, Linda; Miller, Diane B; O'Callaghan, James P 2014. Methamphetamine-induced toxicity: an updated review on issues related to hyperthermia. Pharmacology & therapeutics, 144 1, 28-40Nguyen, Linda; Kaushal, Nidhi; Robson, Matthew J; Matsumoto, Rae R 2014. Sigma receptors as potential therapeutic targets for neuroprotection. European journal of pharmacology, 743 , 42-7Nguyen, Linda; Robson, Matthew J; Healy, Jason R; Scandinaro, Anna L; Matsumoto, Rae R 2014. Involvement of sigma-1 receptors in the antidepressant-like effects of dextromethorphan. PloS one, 9 2, e89985Robson, Matthew J; Turner, Ryan C; Naser, Zachary J; McCurdy, Christopher R; O'Callaghan, James P; Huber, Jason D; Matsumoto, Rae R 2014. SN79, a sigma receptor antagonist, attenuates methamphetamine-induced astrogliosis through a blockade of OSMR/gp130 signaling and STAT3 phosphorylation. Experimental neurology, 254 , 180-9Kaushal, Nidhi; Seminerio, Michael J; Robson, Matthew J; McCurdy, Christopher R; Matsumoto, Rae R 2013. Pharmacological evaluation of SN79, a sigma (?) receptor ligand, against methamphetamine-induced neurotoxicity in vivo. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 23 8, 960-71Robson, Matthew J; Seminerio, Michael J; McCurdy, Christopher R; Coop, Andrew; Matsumoto, Rae R 2013. ? Receptor antagonist attenuation of methamphetamine-induced neurotoxicity is correlated to body temperature modulation. Pharmacological reports : PR, 65 2, 343-9Robson, Matthew J; Turner, Ryan C; Naser, Zachary J; McCurdy, Christopher R; Huber, Jason D; Matsumoto, Rae R 2013. SN79, a sigma receptor ligand, blocks methamphetamine-induced microglial activation and cytokine upregulation. Experimental neurology, 247 , 134-42Turner, Ryan C; Naser, Zachary J; Logsdon, Aric F; DiPasquale, Kenneth H; Jackson, Garrett J; Robson, Matthew J; Gettens, Robert T T; Matsumoto, Rae R; Huber, Jason D; Rosen, Charles L 2013. Modeling clinically relevant blast parameters based on scaling principles produces functional & histological deficits in rats. Experimental neurology, 248 , 520-9Kaushal, Nidhi; Elliott, Meenal; Robson, Matthew J; Iyer, Anand Krishnan V; Rojanasakul, Yon; Coop, Andrew; Matsumoto, Rae R 2012. AC927, a ? receptor ligand, blocks methamphetamine-induced release of dopamine and generation of reactive oxygen species in NG108-15 cells. Molecular pharmacology, 81 3, 299-308Robson, Matthew J; Elliott, Meenal; Seminerio, Michael J; Matsumoto, Rae R 2012. Evaluation of sigma (?) receptors in the antidepressant-like effects of ketamine in vitro and in vivo. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 22 4, 308-17Robson, Matthew J; Noorbakhsh, Bahar; Seminerio, Michael J; Matsumoto, Rae R 2012. Sigma-1 receptors: potential targets for the treatment of substance abuse. Current pharmaceutical design, 18 7, 902-19Seminerio, Michael J; Robson, Matthew J; Abdelazeem, Ahmed H; Mesangeau, Christophe; Jamalapuram, Seshulatha; Avery, Bonnie A; McCurdy, Christopher R; Matsumoto, Rae R 2012. Synthesis and pharmacological characterization of a novel sigma receptor ligand with improved metabolic stability and antagonistic effects against methamphetamine. The AAPS journal, 14 1, 43-51Seminerio, Michael J; Robson, Matthew J; McCurdy, Christopher R; Matsumoto, Rae R 2012. Sigma receptor antagonists attenuate acute methamphetamine-induced hyperthermia by a mechanism independent of IL-1? mRNA expression in the hypothalamus. European journal of pharmacology, 691 1-3, 103-9Turner, Ryan C; Lucke-Wold, Brandon P; Robson, Matthew J; Omalu, Bennet I; Petraglia, Anthony L; Bailes, Julian E 2012. Repetitive traumatic brain injury and development of chronic traumatic encephalopathy: a potential role for biomarkers in diagnosis, prognosis, and treatment? Frontiers in neurology, 3 , 186Xu, Yan-Tong; Robson, Matthew J; Szeszel-Fedorowicz, Wioletta; Patel, Divyen; Rooney, Robert; McCurdy, Christopher R; Matsumoto, Rae R 2012. CM156, a sigma receptor ligand, reverses cocaine-induced place conditioning and transcriptional responses in the brain. Pharmacology, biochemistry, and behavior, 101 1, 174-80Kaushal, Nidhi; Robson, Matthew J; Vinnakota, Harsha; Narayanan, Sanju; Avery, Bonnie A; McCurdy, Christopher R; Matsumoto, Rae R 2011. Synthesis and pharmacological evaluation of 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), a cocaine antagonist, in rodents. The AAPS journal, 13 3, 336-46Fishback, James A; Robson, Matthew J; Xu, Yan-Tong; Matsumoto, Rae R 2010. Sigma receptors: potential targets for a new class of antidepressant drug. Pharmacology & therapeutics, 127 3, 271-82Gengo, Francis M; Rainka, Michelle; Robson, Matthew; Gengo, Michael F; Forrest, Alan; Hourihane, Maurice; Bates, Vernice 2008. Prevalence of platelet nonresponsiveness to aspirin in patients treated for secondary stroke prophylaxis and in patients with recurrent ischemic events. Journal of clinical pharmacology, 48 3, 335-43